Indegene Share Price
601.40+1.25 (+0.21%)
+8.75% past 1 Year
Indegene offers solutions straddling the different stages of the commercialization lifecycle of drugs and medical devices. It caters to the commercial function needs of life sciences companies through its Enterprise
Corporate filings & documents
Announcements
Update on Material Litigation under the Telephone Consumer Protection Act 1991 involving Wholly- Owned Subsidiary Indegene Inc.
3 days agoUpdate on Material Litigation under the Telephone Consumer Protection Act 1991 involving Wholly- Owned Subsidiary Indegene Inc.
3 days agoIntimation of Investors / Analysts Meeting
2 weeks agoIntimation of Investors / Analysts Meeting
2 weeks agoUpdate on Material Litigation under the Telephone Consumer Protection Act 1991 involving Wholly-Owned Subsidiary Indegene Inc.
2 weeks agoUpdate on Material Litigation under the Telephone Consumer Protection Act 1991 involving Wholly-Owned Subsidiary Indegene Inc.
2 weeks agoTranscript of the 28th Annual General Meeting held on August 13 2026
2 weeks agoTranscript of the 28th Annual General Meeting held on August 13 2026
2 weeks agoAppointment of Ms. Jill Mary De Simone (DIN: 11483134) as an independent Director of the Company
2 weeks agoAppointment of Ms. Jill Mary De Simone (DIN: 11483134) as an independent Director of the Company
2 weeks agoScrutinizers Report - 28th Annual General Meeting
2 weeks agoScrutinizers Report - 28th Annual General Meeting
2 weeks agoIntimation of Investors / Analysts Meeting
2 weeks agoIntimation of Investors / Analysts Meeting
2 weeks agoProceedings of the 28th Annual General Meeting of the Company
3 weeks agoProceedings of the 28th Annual General Meeting of the Company
3 weeks agoIntimation of Investors / Analysts Meeting
3 weeks agoIntimation of Investors / Analysts Meeting
3 weeks agoIntimation of Investors / Analysts Meeting
3 weeks agoIntimation of Investors / Analysts Meeting
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for BPC Genesis Fund I- A SPV Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for BPC Genesis Fund I- A SPV Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for BPC Genesis Fund I SPV Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for BPC Genesis Fund I SPV Ltd
3 weeks agoTranscript of earnings conference call on financial results for the quarter ended June 30 2026
4 weeks agoTranscript of earnings conference call on financial results for the quarter ended June 30 2026
4 weeks agoIntimation of Newspaper Publication
1 month agoIntimation of Newspaper Publication
1 month agoAudio Recording of the Q1 FY27 Earnings Call
1 month agoAudio Recording of the Q1 FY27 Earnings Call
1 month agoAnalyst Presentation and fact sheet - financial results for the quarter ended June 30 2026
1 month agoAnalyst Presentation and fact sheet - financial results for the quarter ended June 30 2026
1 month agoPress Release
1 month agoPress Release
1 month agoMonitoring Agency Report
1 month agoMonitoring Agency Report
1 month agoAllotment of Shares under ESOP Scheme 2020
1 month agoAllotment of Shares under ESOP Scheme 2020
1 month agoUnaudited Financial Results for the Quarter ended June 30 2026
1 month agoUnaudited Financial Results for the Quarter ended June 30 2026
1 month agoOutcome of the Board Meeting held on 30th July 2026
1 month agoOutcome of the Board Meeting held on 30th July 2026
1 month agoIntimation of Newspaper Publication
1 month agoIntimation of Newspaper Publication
1 month agoLetter to Shareholders in relation to Annual Report of the Company for the financial year 2025-26
1 month agoLetter to Shareholders in relation to Annual Report of the Company for the financial year 2025-26
1 month agoBusiness Responsibility and Sustainability Report for the financial year 2025-26
1 month agoBusiness Responsibility and Sustainability Report for the financial year 2025-26
1 month agoAnnual Report of the Company for financial year 2025-26
1 month agoAnnual Report of the Company for financial year 2025-26
1 month agoConcalls & investor presentations
Jul 2026
ConcallPresentation
Jul 2026
ConcallPresentation
Apr 2026
ConcallPresentation
Apr 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Oct 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Jul 2025
ConcallPresentation
Apr 2025
ConcallPresentation
Apr 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Oct 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-31
Dividend
2.25
2025-06-13
Dividend
2.0
Company details
Registered office
Aspen G4, 3rd Floor Manyata Embassy Business Park Outer Ring Road, Nagavara Bengaluru Karnataka PIN: 560045 Tel No: 080-46744567 / 46447777 Fax No: 022-46744568 Email: [email protected] Internet: www.indegene.com
Registrars
PIN: Tel No: Fax No: Email:
Management
Srishti Ramesh Kaushik, Company Secretary & Compliance Officer
Manish Gupta, Chairman & Chief Executive Officer
Sanjay Suresh Parikh, Executive Director & Executive Vice President
Krishnamurthy Venugopala Tenneti, Non Executive Independent Director
Ashish Gupta, Non Executive Independent Director
Jairaj Manohar Purandare, Non Executive Independent Director
Pravin Udhyavara Bhadya Rao, Non Executive Independent Director
Georgia Nikolakopoulou Papathomas, Non Executive Independent Director
Neeraj Bharadwaj, Non Executive Independent Director
Rajesh Bhaskaran Nair, Non Executive Director
Mark Dzialga, Nominee Director
Jill Mary De Simone, Non Executive Independent Director
Details
BSE 544172
NSE INDGN
ISIN INE065X01017